CN104352973A - Chinese patent medicine for postpartum depression - Google Patents
Chinese patent medicine for postpartum depression Download PDFInfo
- Publication number
- CN104352973A CN104352973A CN201410631039.3A CN201410631039A CN104352973A CN 104352973 A CN104352973 A CN 104352973A CN 201410631039 A CN201410631039 A CN 201410631039A CN 104352973 A CN104352973 A CN 104352973A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- herba
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 201000009916 Postpartum depression Diseases 0.000 title claims abstract description 24
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 241000921449 Rhodobryum roseum Species 0.000 claims description 8
- 241000244155 Taenia Species 0.000 claims description 8
- 239000010271 massa medicata fermentata Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 229940052810 complex b Drugs 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000002651 drug therapy Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 3
- 239000003826 tablet Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241000432824 Asparagus densiflorus Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 235000010662 Bidens pilosa Nutrition 0.000 abstract 1
- 241000167550 Centella Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 241000756137 Hemerocallis Species 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000921453 Rhodobryum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 241000159213 Zygophyllaceae Species 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 8
- 230000000994 depressogenic effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000008451 emotion Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000020401 Depressive disease Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000003443 Unconsciousness Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 208000020016 psychiatric disease Diseases 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 230000002618 waking effect Effects 0.000 description 3
- 208000014644 Brain disease Diseases 0.000 description 2
- 208000004547 Hallucinations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000035606 childbirth Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010050012 Bradyphrenia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 206010020765 hypersomnia Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention belongs to the technical field of medicines, and relates to a Chinese patent medicine for postpartum depression. The Chinese patent medicine is prepared from the following raw materials: caltrop, red rhodobryum, foldleaf daylily root, poria cocos, uncaria rhynchophylla, dandelion, medicated leaven, bamboo shavings, trichosanthes kirilowii maxim, rhizoma acori graminei, centella, glossy privet fruit, spina date seed, acanthopanax, asparagus fern, fructus forsythia, sticktight, mangnolia officinalis, herba epimedii, humifuse euphorbia herb, mulberry fruit, radix curcumae, radix stemonae, inula flower root, ligusticum wallichii and cassia twig. The dosage forms such as capsules, tablets and granules are prepared according to a conventional pharmaceutical method. The medicine disclosed by the invention is capable of treating both symptoms and root causes of postpartum depression, and is free of a side effect, low in price, easy to prepare, and wide in application prospect.
Description
Technical field
The invention belongs to medical art, concrete, relate to a kind of Chinese patent medicine for postpartum depression.
Background technology
Depression is also known as depressive disorder, low for main clinical characteristics with remarkable and lasting mental state, is the main Types of mood disorders.Clinical visible mental state is low unbecoming with its situation, and the downhearted of emotion can from depressed to extremely grieved, and depression of feeling oneself inferior is even pessimistic and worldweary, can have suicidal attempt or behavior; Even occur numb; Some cases have obvious anxiety and mobility intense; The psychotic symptoms such as hallucination, vain hope can be there is in severe patient.The cause of disease of depression is also unclear, but certainly, and biological, psychology and all many factors of social environment take part in the pathogenic process of depression.Biological factor relates generally to the aspect such as heredity, neural biochemistry, neuroendocrine, neuranagenesis; It is premorbid personality feature that the psychology in close relations with depression easily suffers from quality, as depressed makings.Manhood meets with irritable life events, is the important trigger condition of the paralepsy causing occurring having clinical meaning.But these factors above are not work separately, emphasize reciprocal action between nature-nurture or stressors at present and thisly interactively occur that time point has important impact in depression generating process.
Postpartum depression is, anorexia depressed with puerperal, tired, sleep disorder, absent minded and deal with baby uncomfortable etc. for a kind of nervous symptoms of feature depressed.Hallucination, autotomy, suicide can be there is time serious.Along with the progress in epoch, increasing people follows late marriage and childbirth, lying-in woman advanced in years is allowed to increase year by year, the sickness rate of postpartum depression in recent years is thereupon caused constantly to increase, the course of disease can delay the several months to the several years, the not only physical and mental health of serious harm puerpera, and cognitive competence, personality, emotion, the behavior disorder that may cause baby.
Current western medical treatment mainly takes antidepressant drug, though there is certain curative effect, such medicine likely produces drug dependence and has certain toxic and side effects.
The traditional Chinese medical science thinks that postpartum depression belongs to the categories such as " puerperal goes mad ", " puerperal is demented " " hysteria in puerperal " by its clinical manifestation.Puerperal blood deficiency, internal organs lose support, internal injury caused by excess of seven emotions, internal organs imbalance of YIN and YANG, the deficient or double expectorant of QI and blood is held concurrently in fire, wet, the stasis of blood etc. and is disturbed the main pathogenesis that gods are primary disease.Patient's ferritic is weak insufficiency of the spleen, or vomiting during pregnancy, and essence and blood biochemistry is passive, and after gestation, the poly-lower fetus nourishing of blood, loses blood when producing in addition, to puerperal blood deficiency more very, blood deficiency the liver failing to be nourished, depression of liver-QI, catharsis neglect one's duty, or puerperal hinder in seven emotions, depressed emotion, liver lose bar reach, develop into postpartum depression.Syndrome of stagnation of liver qi, syndrome of disharmony between heart and kidney, syndrome of deficiency of both heart and spleen.Its pathogenesis, many genus QI and blood and visceral dysfunction, deficiency of vital energy blood fortune is smooth, and channels and collaterals running is obstructed.Treatment then, nourish blood reinforcing the heart unobstructed with QI-blood circulation, tranquilizing the mind, waking up the patient from unconsciousness by clearing away phlegm are principle.
The object of this invention is to provide that a kind for the treatment of both the principal and secondary aspects of a disease, side effect are little, safe ready, cheap Chinese medicine composition.Its objective is to solve treatment postpartum depression, overcome Western medicine toxic and side effects large, easily repeatedly, the inapparent problem of therapeutic effect, reaches the object for the treatment of both the principal and secondary aspects of a disease in drug withdrawal.
The defect that present inventor exists based on the medicine of existing Cure of depression, by the research to Chinese medicine, and in conjunction with dialectical demonstration, in many ways the length of many families is collected, seek therapeutic regimen, from motherland's medical treasure-house, filter out reinforcing the heart of nourishing blood, tranquilizing the mind, the natural Chinese medicine of waking up the patient from unconsciousness by clearing away phlegm, by theory of Chinese medical science prescription, skim the cream off milk, it is made to play to clear away heart-fire place tired, YIN nourishing and the production of body fluid promoting, to calm the nerves the effect nourished heart, adopt natural Chinese medicines raw material, through systematic study, scientific compatibility, the Chinese medicine composition for postpartum depression of the present invention is meticulously mixed with in conjunction with Traditional Chinese Medicine technology, postpartum depression is had to effect of rapid healing.
For achieving the above object, the technical solution used in the present invention is as follows:
For a Chinese patent medicine for postpartum depression, it is characterized in that it is prepared by following raw material and obtains,
Fructus Tribuli, Rhodobryum roseum Limpr., Radix hemerocalis plicatae, Poria, Ramulus Uncariae Cum Uncis, Herba Taraxaci, Massa Medicata Fermentata, Caulis Bambusae In Taenia, Fructus Trichosanthis, Rhizoma Acori Graminei, Herba Centellae, Fructus Ligustri Lucidi, Semen Ziziphi Spinosae, Radix Et Caulis Acanthopanacis Senticosi, Radix Asparagi, Fructus Forsythiae, Herba Bidentis Bipinnatae, Cortex Magnoliae Officinalis, Herba Epimedii, Herba Euphorbiae Humifusae, Fructus Mori, Radix Curcumae, the Radix Stemonae, Radix Inulae, Rhizoma Chuanxiong, Ramulus Cinnamomi.
For a Chinese patent medicine for postpartum depression, it is characterized in that it is prepared by following weight proportioning raw material and obtains,
Fructus Tribuli 30 parts, Rhodobryum roseum Limpr. 30 parts, Radix hemerocalis plicatae 30 parts, 30 parts, Poria,
Ramulus Uncariae Cum Uncis 25 parts, Herba Taraxaci 25 parts, Massa Medicata Fermentata 25 parts, Caulis Bambusae In Taenia 25 parts,
Fructus Trichosanthis 22 parts, Rhizoma Acori Graminei 22 parts, Herba Centellae 22 parts, Fructus Ligustri Lucidi 22 parts,
Semen Ziziphi Spinosae 20 parts, Radix Et Caulis Acanthopanacis Senticosi 20 parts, Radix Asparagi 20 parts, Fructus Forsythiae 20 parts,
Herba Bidentis Bipinnatae 18 parts, Cortex Magnoliae Officinalis 18 parts, Herba Epimedii 15 parts, Herba Euphorbiae Humifusae 15 parts,
Fructus Mori 10 parts, Radix Curcumae 10 parts, the Radix Stemonae 10 parts, Radix Inulae 8 parts,
Rhizoma Chuanxiong 5 parts, Ramulus Cinnamomi 5 parts.
Medicine of the present invention can add one or more pharmaceutically acceptable carriers and be mixed and made into any one clinically or pharmaceutically acceptable dosage form, preferred oral preparation.When being applied in the mode of oral administration the patient needing this treatment, conventional solid preparation can be made into, as tablet, capsule, soft capsule etc.
Preferably, its preparation method is:
(1) get Fructus Tribuli, Rhodobryum roseum Limpr., Radix hemerocalis plicatae, Poria, Ramulus Uncariae Cum Uncis, Herba Taraxaci, Massa Medicata Fermentata, Caulis Bambusae In Taenia, Fructus Trichosanthis, Herba Epimedii, Herba Euphorbiae Humifusae, Fructus Mori, Radix Curcumae, the Radix Stemonae, Radix Inulae mix in described ratio, add the ethanol relative to mixture 3-5 times amount 95%, reflux, extract, 3 times, each 2 hours, extracting solution merges, and is concentrated into the clear paste that density is 1.25g/ml, 80 DEG C of oven dry, be ground into powder, be complex A;
(2) get surplus stock medicine and add 5 times of soak by water twice, 2 hours first times, second time 1 hour, merges twice decoction liquor, and it is the extractum of 1.25g/ml that drying under reduced pressure obtains density, after 80 DEG C of oven dry, is ground into powder, is complex B;
(3) by complex A and complex B mixing and stirring, sterilization obtains capsule product.
Chinese medicine mind tranquilizing and the heart calming of the present invention, reinforcing the heart of nourishing blood, tranquilizing the mind, waking up the patient from unconsciousness by clearing away phlegm nourishing the liver and kidney, have definite curative effect to postpartum depression, side effect is little.Fill blood, nourish heart kidney.
Usage and dosage: oral, a 1g, three times on the one.
Attention: hyperpietic avoids clothes, warm water delivery service.Period in a medicine avoids pungent food and cold and cool food, and avoid emotional stimulation, life is regular.
The Chinese patent medicine excellent results that the present invention is used for postpartum depression is:
1. the present invention meets Chinese medicine " monarch " principle for the Chinese medicine preparation compatibility of postpartum depression, be made up of pure Chinese medicine, each component meets pharmaceutical control law regulation, utilize the comprehensive function of each taste Chinese medicine, not containing chemical components, not containing hormone, have no side effect, treating both the exterior and interior, reaches better enriching yin and nourishing kidney, tranquilizing by nourishing the heart effect;
2. this medicament short treating period, total effective rate is high, not easily recurs more.
3. technique of the present invention is simple, reduces production cost, alleviates the financial burden of patient.
Detailed description of the invention
Embodiment 1
For a Chinese patent medicine for postpartum depression, it is prepared by following weight proportioning raw material and obtains
Fructus Tribuli 30 parts, Rhodobryum roseum Limpr. 30 parts, Radix hemerocalis plicatae 30 parts, 30 parts, Poria,
Ramulus Uncariae Cum Uncis 25 parts, Herba Taraxaci 25 parts, Massa Medicata Fermentata 25 parts, Caulis Bambusae In Taenia 25 parts,
Fructus Trichosanthis 22 parts, Rhizoma Acori Graminei 22 parts, Herba Centellae 22 parts, Fructus Ligustri Lucidi 22 parts,
Semen Ziziphi Spinosae 20 parts, Radix Et Caulis Acanthopanacis Senticosi 20 parts, Radix Asparagi 20 parts, Fructus Forsythiae 20 parts,
Herba Bidentis Bipinnatae 18 parts, Cortex Magnoliae Officinalis 18 parts, Herba Epimedii 15 parts, Herba Euphorbiae Humifusae 15 parts,
Fructus Mori 10 parts, Radix Curcumae 10 parts, the Radix Stemonae 10 parts, Radix Inulae 8 parts,
Rhizoma Chuanxiong 5 parts, Ramulus Cinnamomi 5 parts.
Its preparation method is:
(1) get Fructus Tribuli, Rhodobryum roseum Limpr., Radix hemerocalis plicatae, Poria, Ramulus Uncariae Cum Uncis, Herba Taraxaci, Massa Medicata Fermentata, Caulis Bambusae In Taenia, Fructus Trichosanthis, Herba Epimedii, Herba Euphorbiae Humifusae, Fructus Mori, Radix Curcumae, the Radix Stemonae, Radix Inulae mix in described ratio, add the ethanol relative to mixture 3 times of weight 95%, reflux, extract, 3 times, each 2 hours, extracting solution merges, and is concentrated into the clear paste that density is 1.25g/ml, 80 DEG C of oven dry, be ground into powder, be complex A;
(2) surplus stock medicine and Rhizoma Acori Graminei, Herba Centellae, Fructus Ligustri Lucidi, Semen Ziziphi Spinosae, Radix Et Caulis Acanthopanacis Senticosi, Radix Asparagi, Fructus Forsythiae, Herba Bidentis Bipinnatae, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Ramulus Cinnamomi is got, add 5 times of soak by water twice, 2 hours first times, second time 1 hour, merge twice decoction liquor, it is the extractum of 1.25g/ml that decoction liquor drying under reduced pressure is obtained density, after 80 DEG C of oven dry, be ground into powder, be complex B;
(3) by complex A and complex B mixing and stirring, sterilization obtains capsule product.
Usage and dosage: oral, a 1g, three times on the one.
Embodiment 2
Studies on acute toxicity
Acute toxicity testing: application mice 40, male and female half and half, body weight 30 ~ 40g, carries out acute toxicity test.Mice is divided into two groups at random, i.e. matched group and administration group, often organize 20, fasting 12 hours before experiment, Chinese patent medicine prepared by embodiments of the invention 1 is dissolved in gastric infusion in water (gavage unit dosage form is 50g crude drug/kg), matched group gives normal saline, administration in one day 2 times, delivery time 6 hours, Continuous Observation 14 days after administration, and record mice toxic reaction and death toll.Experimental result shows: compare with matched group, and after administration, mice has no notable difference, and experiment Continuous Observation 14 days, mouse systemic situation, diet, drinking-water, body weight increase all normal.Therefore Chinese patent medicine acute toxicity of the present invention is extremely low, clinical drug safety.
Long term toxicity test: Chinese medicine embodiment 1 capsule of the present invention is to mice continuous use 15 weeks and drug withdrawal after 3 weeks, result shows: the index such as hair, behavior, defecation, body weight, organ weights, hemogram, hepatic and renal function, blood glucose, blood fat of Chinese medicine of the present invention to mice all has no significant effect, internal organs naked eyes do not find that difference change and histological indications show, medication 15 weeks and drug withdrawal are after 3 weeks, and Organs of Mice is all without obviously changing.Illustrate that Chinese medicine of the present invention is little to toxicity after mice long-term prescription, also there is no difference reaction after drug withdrawal, application safety.
Embodiment 3
1, clinical data
Choose patient 107 example with complete data, be divided into two groups immediately, treatment group and matched group, wherein treatment group 53 people, 21 ~ 40 years old age, primipara 39 example, multipara 14 example; Cesarean 31 example, spontaneous labor 22 example; Patients with mild 7 example, moderate patient 37 example, severe patient 9 example; Matched group 54 people, 20 ~ 39 years old age, primipara 38 example, multipara 16 example; Cesarean 30 example, spontaneous labor 24 example; Patients with mild 8 example, moderate patient 36 example, severe patient 10 example.Two groups in age, childbirth options, parturition number, symptom and coincident with severity degree of condition etc. through statistical analysis there was no significant difference (p>0.05).There is comparability.
1, diagnostic criteria: the diagnostic criteria according to postpartum depression in Americanism association " diagnostic & statistical manual of mental sickness ": the symptom (at least one item in first 2 must be possessed) occurring following more than 5 or 5 within two weeks puerperal: be 1. in a very depressed state; 2. to all or most movable interest and joyful of obviously lacking; 3. body weight significantly declines or increases; 4. insomnia or hypersomnia; 5. psychomotor excitement or retardance; 6. tired or weak; 7. all feel meaningless when anything crops up or have from crime sense; 8. thinking ability go down or attention defeated and dispersed; 9. repeatedly there is dead idea.All patients get rid of brain disorder, mental disorder history, mental disorder family history.Depressive illness is divided into 3 degree according to Hamilton depressive scale (HAMD scale) standards of grading: slight: total score at 8 ~ 20 points, moderate: total score at 21 ~ 35 points, severe: total score is more than 35 points.
Therapeutic Method:
Matched group: oral paroxetine, every day 20mg, 1 time on the 1st, 8 weeks courses for the treatment of.
Treatment group: give Chinese medicine embodiment 1 capsule of the present invention each 1g, every day 3 times, 8 weeks courses for the treatment of.
Two groups all give psychological counseling, and adjustment patient emotion, establishes the confidence of Fighting Disease.
Curative effect judging standard: before treating, treated for 2,4,8 weekends, using the deduction rate of HAMD scale score as parameters for observation on effect, total mark before deduction rate=(before treatment the rear total mark of total mark-treatment)/treatment, adopt 4 grade standards that the whole nation is unified: clinical cure: transference cure, HAMD (deduction to 7 point below) deduction rate >=80%;
Effective: symptom major part disappears, 50%≤HAMD deduction rate <80%;
Take a turn for the better: symptom partial disappearance or degree alleviate, 25%≤HAMD deduction rate <50%;
Invalid: symptom is unchanged or increase the weight of, HAMD deduction rate <25%.
Therapeutic outcome: treatment group and comparing, in table 1 complying total effects.
| Group | Example time | Recovery from illness | Effective | Effectively | Invalid | Total effective rate (%) |
| Treatment group | 53 | 20 | 19 | 10 | 4 | 92.4 |
| Matched group | 54 | 9 | 20 | 13 | 12 | 77.7 |
As seen from the above table: cure rate and the total effective rate for the treatment of group are all obviously better than matched group, have significant difference.
Embodiment 3
Exemplary embodiments
Jiang, 37 years old, advanced age multipara, Cesarean esction.Occur depression phenomenon in puerperal, it is postpartum depression that doctor is diagnosed as, and treat for Jiang opens medicine, take medicine after 3 wheat harvesting periods, the state of an illness does not take a turn for the better; After giving the capsule preparations of embodiment 1 preparation, through about 2 months take, and the psychological auxiliary treatment of necessity, conditions of patients is clearly better, and checks, substantially fully recover through doctor.Follow up a case by regular visits to half a year without recurrence.
Liu, 29 years old, primipara.Cesarean before 3 months, postpartum hemorrhage is many, depressed because occurring after house hold affairs quarrel, bradyphrenia, insomnia and dreamful sleep, and tired weak, the symptoms such as attention is defeated and dispersed, get rid of brain diseases and mental disorder history, be diagnosed as postpartum depression.Give the capsule preparations of Chinese medicine embodiment 1 of the present invention preparation, give psychological consultation treatment simultaneously.After treating 8 weeks, clinical cure.Follow up a case by regular visits to and do not recur half a year.
Above-mentioned each Chinese medicinal components that the present invention adopts makes compatibility mutually, its collaborative effect of curing the disease can be played, there is between each composition of raw material of Chinese medicine used drug effect be interweaved and mutually promote and coordinate usefulness, through clinical verification, have good therapeutic effect to postpartum depression, in the applicant's medical practice for many years, the case Numerous of curing, all obtains good effect, and with low cost, alleviate the burden of patient, have broad application prospects.
Claims (4)
1. for a Chinese patent medicine for postpartum depression, it is characterized in that, described Chinese patent medicine is prepared by following crude drug and obtains,
Fructus Tribuli, Rhodobryum roseum Limpr., Radix hemerocalis plicatae, Poria, Ramulus Uncariae Cum Uncis, Herba Taraxaci, Massa Medicata Fermentata, Caulis Bambusae In Taenia, Fructus Trichosanthis, Rhizoma Acori Graminei, Herba Centellae, Fructus Ligustri Lucidi, Semen Ziziphi Spinosae, Radix Et Caulis Acanthopanacis Senticosi, Radix Asparagi, Fructus Forsythiae, Herba Bidentis Bipinnatae, Cortex Magnoliae Officinalis, Herba Epimedii, Herba Euphorbiae Humifusae, Fructus Mori, Radix Curcumae, the Radix Stemonae, Radix Inulae, Rhizoma Chuanxiong, Ramulus Cinnamomi.
2. Chinese patent medicine according to claim 1, is characterized in that, described Chinese patent medicine is prepared by the crude drug of following weight portion and obtains,
Fructus Tribuli 30 parts, Rhodobryum roseum Limpr. 30 parts, Radix hemerocalis plicatae 30 parts, 30 parts, Poria,
Ramulus Uncariae Cum Uncis 25 parts, Herba Taraxaci 25 parts, Massa Medicata Fermentata 25 parts, Caulis Bambusae In Taenia 25 parts,
Fructus Trichosanthis 22 parts, Rhizoma Acori Graminei 22 parts, Herba Centellae 22 parts, Fructus Ligustri Lucidi 22 parts,
Semen Ziziphi Spinosae 20 parts, Radix Et Caulis Acanthopanacis Senticosi 20 parts, Radix Asparagi 20 parts, Fructus Forsythiae 20 parts,
Herba Bidentis Bipinnatae 18 parts, Cortex Magnoliae Officinalis 18 parts, Herba Epimedii 15 parts, Herba Euphorbiae Humifusae 15 parts,
Fructus Mori 10 parts, Radix Curcumae 10 parts, the Radix Stemonae 10 parts, Radix Inulae 8 parts,
Rhizoma Chuanxiong 5 parts, Ramulus Cinnamomi 5 parts.
3. the preparation method of Chinese patent medicine described in claim 1-2, is characterized in that, described preparation method comprises the steps:
(1) Fructus Tribuli, Rhodobryum roseum Limpr., Radix hemerocalis plicatae, Poria, Ramulus Uncariae Cum Uncis, Herba Taraxaci, Massa Medicata Fermentata, Caulis Bambusae In Taenia, Fructus Trichosanthis, Herba Epimedii, Herba Euphorbiae Humifusae, Fructus Mori, Radix Curcumae, the Radix Stemonae, Radix Inulae is got, mixing, add the ethanol relative to mixture 3-5 times weight 95%, reflux, extract, 3 times, each 2 hours, extracting solution merged, be concentrated into the clear paste that density is 1.25g/ml, 80 DEG C of oven dry, are ground into powder, are complex A;
(2) get surplus stock medicine, add 5 times of soak by water twice, 2 hours first times, second time 1 hour, merges twice decoction liquor, and it is the extractum of 1.25g/ml that drying under reduced pressure obtains density, after 80 DEG C of oven dry, is ground into powder, is complex B;
(3) by complex A and complex B mixing and stirring, sterilization obtains capsule product.
4. Chinese patent medicine described in claim 1-3 is used for the purposes in postpartum depression Drug therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410631039.3A CN104352973A (en) | 2014-11-12 | 2014-11-12 | Chinese patent medicine for postpartum depression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410631039.3A CN104352973A (en) | 2014-11-12 | 2014-11-12 | Chinese patent medicine for postpartum depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104352973A true CN104352973A (en) | 2015-02-18 |
Family
ID=52520346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410631039.3A Pending CN104352973A (en) | 2014-11-12 | 2014-11-12 | Chinese patent medicine for postpartum depression |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104352973A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105617279A (en) * | 2016-03-03 | 2016-06-01 | 林炜 | Preparation method of traditional Chinese medicine for treating depression |
| AU2015203074B1 (en) * | 2015-06-10 | 2016-10-20 | Thisherb Health Pty Ltd | Pharmaceutical composition for treatment of depression and preparation method thereof |
-
2014
- 2014-11-12 CN CN201410631039.3A patent/CN104352973A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 王秀珍 等: "中西医结合治疗产后抑郁症60例", 《中国中医药现代远程教育》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015203074B1 (en) * | 2015-06-10 | 2016-10-20 | Thisherb Health Pty Ltd | Pharmaceutical composition for treatment of depression and preparation method thereof |
| EP3307294A4 (en) * | 2015-06-10 | 2018-05-30 | Thisherb Health Pty Ltd. | Pharmaceutical composition for treatment of depression and preparation method thereof |
| JP2018516995A (en) * | 2015-06-10 | 2018-06-28 | ディスハーブ ヘルス ピーティーワイ リミテッドＴｈｉｓｈｅｒｂ Ｈｅａｌｔｈ Ｐｔｙ Ｌｔｄ | Pharmaceutical composition for the treatment of depression and method for its preparation |
| CN105617279A (en) * | 2016-03-03 | 2016-06-01 | 林炜 | Preparation method of traditional Chinese medicine for treating depression |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105998297B (en) | A kind of Chinese medicine composition for relaxing bowel and preparation method thereof | |
| CN101444611B (en) | Traditional Chinese medicine composition for treating lumbocrural pain and lumbar intervertebral disc protrusion and preparation method thereof | |
| CN104274789A (en) | Traditional Chinese medicine composition for treating depression | |
| CN104983985B (en) | A kind of Chinese medicine preparation of Cure of depression | |
| CN105497261A (en) | Matrix of patch for external use and patch and sleeping-aid patch made from matrix | |
| CN101711809A (en) | Medicine composition for treating postpartum melancholia, preparation method and application | |
| CN101700336A (en) | Chinese herba preparation for curing craniocerebra trauma residual headache | |
| CN104667199A (en) | Pharmaceutical preparation for treating mental anxiety and application of pharmaceutical preparation | |
| CN104352973A (en) | Chinese patent medicine for postpartum depression | |
| CN104383421A (en) | Pharmaceutical preparation for treating insomnia and dreaminess | |
| CN104383420A (en) | Preparation method of pharmaceutical preparation for treating insomnia and dreaminess | |
| CN104623314A (en) | Medicine composition for treating dry mouth and bitter taste and preparation method thereof | |
| CN104324134B (en) | One kind improves microcirculatory Chinese medicine composition and preparation method thereof | |
| CN103638336B (en) | Full rhizoma gastrodiae tablet | |
| CN103784893B (en) | A kind of medicine for the treatment of cerebral apoplexy sequela | |
| CN102716260B (en) | Medicine for fast improving sperm quality and sexual function | |
| CN104383441A (en) | Method for preparing Chinese patent medicine for treating postpartum depression | |
| CN103393938B (en) | Traditional Chinese medicine composition for reducing blood sugar | |
| CN102579818A (en) | Traditional Tibetan medicine composition, preparation method thereof and application | |
| CN105343675A (en) | Traditional Chinese medicine preparation for treating adiposis and preparation method thereof | |
| CN105998752B (en) | A kind of Chinese medicine composition for the treatment of of vascular dementia | |
| CN104740210B (en) | A kind of Chinese medicine and preparation method for the treatment of qi stagnation and blood stasis type craniocerebral trauma syndrome | |
| CN104605051A (en) | Double hemp-folium cortex eucommiae tea and preparing method thereof | |
| CN108379367A (en) | Pure Chinese medicine drug of drug rehabilitation and preparation method thereof | |
| CN104645246B (en) | A kind of pharmaceutical preparation depressed for Menopause |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150218 |
|
| RJ01 | Rejection of invention patent application after publication |